ARTICLE | Company News
Celltrion, Medigene, German Cancer Research Center deal
July 21, 2008 7:00 AM UTC
MediGene exercised an option to acquire an exclusive, worldwide license from the center to develop and commercialize a mAb against L1 cell adhesion molecule ( L1CAM, CD171) to treat cancer under a 2...